BR0108727A - Composição micelar para o tratamento de doenças parasìticas em animais, e, uso de uma composição - Google Patents

Composição micelar para o tratamento de doenças parasìticas em animais, e, uso de uma composição

Info

Publication number
BR0108727A
BR0108727A BR0108727-4A BR0108727A BR0108727A BR 0108727 A BR0108727 A BR 0108727A BR 0108727 A BR0108727 A BR 0108727A BR 0108727 A BR0108727 A BR 0108727A
Authority
BR
Brazil
Prior art keywords
composition
treatment
micellar
animals
parasitic diseases
Prior art date
Application number
BR0108727-4A
Other languages
English (en)
Inventor
Rahman Shoa A Abdul
Original Assignee
New Pharma Res Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Pharma Res Sweden Ab filed Critical New Pharma Res Sweden Ab
Publication of BR0108727A publication Critical patent/BR0108727A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO MICELAR PARA O TRATAMENTO DE DOENçAS PARASìTICAS EM ANIMAIS, E, USO DE UMA COMPOSIçãO". Composições não aquosas ou aquosas micelares para o tratamento terapêutico de doenças de animais causadas por vermes ou nematódeos parasíticos, compreendendo rafoxanida e combinações específicas de solventes que atuam como agentes promotores da estabilização e absorção. Os solventes são selecionados de agentes tensoativos não iónicos tais como Tween <32> 80 e de N-metilpirrolidona, 2-pirrolidona ou dimetilsulfóxido. As composições são fáceis de se preparar, estáveis após a armazenagem e podem ser administradas oralmente, por injeção ou topicamente. Com estas formulações, uma melhora da eficácia de rafoxanida no tratamento das doenças é observada.
BR0108727-4A 2000-02-29 2001-02-22 Composição micelar para o tratamento de doenças parasìticas em animais, e, uso de uma composição BR0108727A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00104126A EP1129713A1 (en) 2000-02-29 2000-02-29 Veterinary compositions for the treatment of parasitic diseases
PCT/EP2001/002037 WO2001064222A1 (en) 2000-02-29 2001-02-22 Veterinary compositions for the treatment of parasitic diseases

Publications (1)

Publication Number Publication Date
BR0108727A true BR0108727A (pt) 2002-11-05

Family

ID=8167975

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108727-4A BR0108727A (pt) 2000-02-29 2001-02-22 Composição micelar para o tratamento de doenças parasìticas em animais, e, uso de uma composição

Country Status (11)

Country Link
US (2) US6777448B2 (pt)
EP (2) EP1129713A1 (pt)
CN (1) CN1213756C (pt)
AT (1) ATE247970T1 (pt)
AU (2) AU3548901A (pt)
BR (1) BR0108727A (pt)
DE (1) DE60100666T2 (pt)
ES (1) ES2206406T3 (pt)
NZ (1) NZ521533A (pt)
TR (1) TR200302027T4 (pt)
WO (1) WO2001064222A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
KR20050103685A (ko) * 2004-04-27 2005-11-01 삼성전자주식회사 액정 표시 장치용 휘도 강화 필름 및 그 제조 방법
GB0711957D0 (en) * 2007-06-21 2007-08-01 Syntopix Ltd Formulations
DE102010051404B4 (de) 2010-11-16 2017-08-31 Marc de Cocq Verwendung von substituierten Salicylaniliden zur Behandlung von Fischen
RU2569740C1 (ru) * 2014-05-20 2015-11-27 Рамзия Тимергалеевна Маннапова Способ коррекции минерального обмена при диктиокаулезе овец
CN104800158A (zh) * 2015-04-14 2015-07-29 四川美嘉龙生物科技有限公司 一种碘醚柳胺制剂及制备方法
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL184257C (nl) * 1974-06-19 1989-06-01 Merck & Co Inc Werkwijze voor het bereiden van rafoxanide preparaten.
US4128632A (en) * 1978-02-13 1978-12-05 Merck & Co., Inc. Solubilization of Rafoxanide
AU527154B2 (en) * 1978-12-15 1983-02-17 Pitman-Moore Australia Limited Composition and process
ZA842571B (en) * 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
IE58016B1 (en) * 1983-08-12 1993-06-16 Ici Australia Ltd Pour-on formulation for the control of parasites
NZ209100A (en) * 1983-08-22 1987-01-23 Ici Australia Ltd Topical compositions for control of endoparasites
AU5733986A (en) * 1985-05-13 1986-11-20 Syntex (U.S.A.) Inc. Anthelmintic compositions comprising a benzimidazole derivative and the fasciolicide rafoxanide
US5340804A (en) * 1991-11-14 1994-08-23 Eli Lilly And Company 1,5-diphenyl-3-formazancarbonitril parasiticides
AU698431B2 (en) * 1993-12-13 1998-10-29 Michael Hilary Burke Anthelmintic composition containing rafoxanide and fenbendazole
EP1137627A1 (en) 1998-12-10 2001-10-04 Bayer Aktiengesellschaft Process for the preparation of strobilurin intermediates

Also Published As

Publication number Publication date
EP1129713A1 (en) 2001-09-05
DE60100666T2 (de) 2004-06-24
WO2001064222A1 (en) 2001-09-07
US20040072909A1 (en) 2004-04-15
CN1213756C (zh) 2005-08-10
US20030049309A1 (en) 2003-03-13
ES2206406T3 (es) 2004-05-16
DE60100666D1 (de) 2003-10-02
TR200302027T4 (tr) 2004-01-21
AU3548901A (en) 2001-09-12
NZ521533A (en) 2003-03-28
ATE247970T1 (de) 2003-09-15
CN1406130A (zh) 2003-03-26
EP1259244A1 (en) 2002-11-27
US6777448B2 (en) 2004-08-17
AU2001235489B2 (en) 2004-11-18
EP1259244B1 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
IL208697A0 (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
BR0300949A (pt) Composto de éster e seu uso
DK1345611T3 (da) Antibiotisk/analgetisk formulering og en fremgangsmåde til fremstilling deraf
CY1112106T1 (el) Σκευασματα παραθυρεοεiδους ορμονης και η χρηση τους
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
DK0722313T3 (da) Viskoelastiske sammensætninger af fluorerede organiske forbindelser
EA200702593A1 (ru) Высококонцентрированные композиции, применимые для борьбы с экто- и эндопаразитами
EA200701986A1 (ru) Улучшенные составы фенофибрата, содержащие ментол или смесь пэг/полоксамера
BRPI0418115A (pt) formulação lìquida estável de hormÈnio de crescimento
BRPI0415906A (pt) formulão inseticida
PE20040324A1 (es) Formulaciones liquidas de baja dosis de entecavir y uso
BR0108727A (pt) Composição micelar para o tratamento de doenças parasìticas em animais, e, uso de uma composição
KR20080011224A (ko) 외부 기생충 억제용 겔 조성물
WO2001051028A3 (en) Formulations and methods for administration of pharmacologically or biologically active compounds
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
ATE290400T1 (de) Zusammensetzung zur behandlung von degenerativen gelenkerkrankungen
DE60135845D1 (de) Pralmorelin-haltige nasentropfen-präparate
AR034835A1 (es) Composicion micelar para el tratamiento de enfermedades parasitarias en animales y uso de dicha composicion.
ES2102370T3 (es) Composicion antiparasitaria para uso animal.
ATE433743T1 (de) Ternäre eutektische gemische von lokalanaesthetika
BR0215498A (pt) Composição farmacêutica compreendendo uma glitazona e um ácido 4-oxobutanóico e o seu uso para o tratamento de diabetes
TH71075A (th) องค์ประกอบของสารให้ความหอมเทอร์ปีนอยด์ที่ทำให้เสถียรด้วยเกลือของกรดมาโลนิก
JO2214B1 (en) Veterinary formulations to treat parasitic diseases
RU2000121830A (ru) Лекарственный препарат для лечения кожных болезней собак и кошек

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: NEW PHARMA RESEARCH SWEDEN AB (SE)

Free format text: ALTERADA A SEDE DO TITULAR CONFORME SOLICITADO NA PETICAO NO 035799/RJ DE 30/06/2003.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 12A E 13A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 12A, 13A, 14A, 15A, 16A, 17A, 18A E 19A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.